HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+4.77%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.75B
AUM Growth
+$1.75B
(+3.5%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-2.47%
Top 10 Holdings %
Top 10 Hldgs %
60.52%
Holding
53
New
15
Increased
13
Reduced
11
Closed
12
Top Buys
| 1 |
Hologic
HOLX
|
$138M |
| 2 |
Biogen
BIIB
|
$115M |
| 3 |
Edwards Lifesciences
EW
|
$67.3M |
| 4 |
AET
Aetna Inc
AET
|
$61.1M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$58.4M |
Top Sells
| 1 |
DexCom
DXCM
|
$109M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$106M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$92.7M |
| 4 |
Zimmer Biomet
ZBH
|
$60.2M |
| 5 |
Quest Diagnostics
DGX
|
$57M |
Sector Composition
| 1 | Healthcare | 82.14% |
| 2 | Financials | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Edwards Lifesciences
EW
$47.8B
| $150M | 8.16% | 1,500,000 +675,000 | +82% | +$67.3M |
|
2
Labcorp
LH
$23.1B
| $143M | 7.82% | 1,100,000 +150,000 | +16% | +$19.5M |
|
|
3
Hologic
HOLX
$14.9B
| $138M | 7.55% | +4,000,000 | New | +$138M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $122M | 6.66% | 1,000,000 +500,000 | +100% | +$61.1M |
|
|
5
Zimmer Biomet
ZBH
$21B
| $120M | 6.57% | 1,000,000 -500,000 | -33% | -$60.2M |
|
|
6
Biogen
BIIB
$19.4B
| $115M | 6.26% | +475,000 | New | +$115M |
|
|
7
Quest Diagnostics
DGX
$20.3B
| $93.6M | 5.11% | 1,150,000 -700,000 | -38% | -$57M |
|
|
AKRX
8
DELISTED
Akorn, Inc.
AKRX
| $59.8M | 3.26% | 2,100,000 -1,075,000 | -34% | -$30.6M |
|
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $58.4M | 3.18% | +750,000 | New | +$58.4M |
|
10
Encompass Health
EHC
$12.3B
| $56.3M | 3.07% | 1,450,000 +350,000 | +32% | +$13.6M |
|
|
QGENF
11
DELISTED
QIAGEN NV
QGENF
| $54.5M | 2.97% | +2,500,000 | New | +$54.5M |
|
|
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
| $41.4M | 2.26% | +496,680 | New | +$41.4M |
|
|
HRC
13
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $41.1M | 2.24% | +815,603 | New | +$41.1M |
|
14
Humana
HUM
$36.5B
| $38.7M | 2.11% | 214,920 +14,920 | +7% | +$2.68M |
|
15
Acadia Healthcare
ACHC
$2.12B
| $37.9M | 2.07% | +684,220 | New | +$37.9M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $36.4M | 1.98% | 2,650,000 +650,000 | +33% | +$8.92M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $34.5M | 1.88% | 233,245 -141,755 | -38% | -$20.9M |
|
18
Icon
ICLR
$13.8B
| $33.3M | 1.81% | 475,000 +73,600 | +18% | +$5.15M |
|
19
Universal Health Services
UHS
$11.6B
| $32.7M | 1.78% | 243,490 -381,510 | -61% | -$51.2M |
|
|
20
DexCom
DXCM
$29.5B
| $31.4M | 1.71% | 396,030 -1,378,970 | -78% | -$109M |
|
21
Revvity
RVTY
$10.5B
| $30.5M | 1.67% | +582,500 | New | +$30.5M |
|
|
CVRS
22
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $28.6M | 1.56% | 19,981,655 | – | – |
|
|
EVHC
23
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $26.7M | 1.46% | +1,052,160 | New | +$26.7M |
|
24
CVS Health
CVS
$92.8B
| $22.8M | 1.24% | +237,830 | New | +$22.8M |
|
25
Gilead Sciences
GILD
$140B
| $22.6M | 1.23% | +270,680 | New | +$22.6M |
|